Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000929638-24-004038
Filing Date
2024-11-25
Accepted
2024-11-25 11:03:18
Documents
1
Period of Report
2024-11-18

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3103
  Complete submission text file 0000929638-24-004038.txt   4778
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

EIN.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 5TH FLOOR, BUILDING D 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD NANJING F4 210061
Business Address 5TH FLOOR, BUILDING D 3-1 ZHONGDAN UNIT, SOUTH LONGSHAN RD NANJING F4 210061 267-356-9574
Biosion, Inc. (Reporting) CIK: 0002045933 (see all company filings)

State of Incorp.: F4 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37581 | Film No.: 241492934